Human disposition, metabolism and excretion of etamicastat, a reversible, peripherally selective dopamine β-hydroxylase inhibitor.

about

Distribution and pharmacokinetics of etamicastat and its N-acetylated metabolite (BIA 5-961) in dog and monkey.Glucuronidation: driving factors and their impact on glucuronide disposition

P2860

Q53544427-6A88B7A8-D501-4781-ACB7-B61D883C0C8F Q56030213-841639A2-3454-4986-81E4-4ABBD2781797

P2860

Human disposition, metabolism and excretion of etamicastat, a reversible, peripherally selective dopamine β-hydroxylase inhibitor.

Item

http://www.wikidata.org/entity/Q41968208

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Human disposition, metabolism ...... amine β-hydroxylase inhibitor.

@en

type

Item

label

Human disposition, metabolism ...... amine β-hydroxylase inhibitor.

@en

prefLabel

Human disposition, metabolism ...... amine β-hydroxylase inhibitor.

@en

P1476

Human disposition, metabolism ...... pamine β-hydroxylase inhibitor

@en

P2093

Ana I Loureiro

http://www.w3.org/2001/XMLSchema#string

Carlos Fernandes-Lopes

http://www.w3.org/2001/XMLSchema#string

Jose F Rocha

http://www.w3.org/2001/XMLSchema#string

Lyndon C Wright

http://www.w3.org/2001/XMLSchema#string

Teresa Nunes

http://www.w3.org/2001/XMLSchema#string

P2860

Safety, Tolerability, and Pharmacokinetics of Etamicastat, a Novel Dopamine-β-Hydroxylase Inhibitor, in a Rising Multiple-Dose Study in Young Healthy Subjects

Dopamine and G protein-coupled receptor kinase 4 in the kidney: role in blood pressure regulation.

Dopamine beta-hydroxylase deficiency. A genetic disorder of cardiovascular regulation.

Update on the pharmacogenetics of NATs: structural considerations.

Pharmacokinetics and tolerability of etamicastat following single and repeated administration in elderly versus young healthy male subjects: an open-label, single-center, parallel-group study.

Intestinal secretion is a major route for parent ivermectin elimination in the rat.

Synthesis and biological evaluation of novel, peripherally selective chromanyl imidazolethione-based inhibitors of dopamine beta-hydroxylase.

Pharmacogenetics of the arylamine N-acetyltransferases: a symposium in honor of Wendell W. Weber.

P304

1017-1026

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/BCP.12274

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Patrício Soares-da-Silva

Luis Almeida

P577

2014-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

258146115

http://www.w3.org/2001/XMLSchema#string

P698

24168152

http://www.w3.org/2001/XMLSchema#string

P932

4093927

http://www.w3.org/2001/XMLSchema#string

Human disposition, metabolism and excretion of etamicastat, a reversible, peripherally selective dopamine β-hydroxylase inhibitor.

about

P2860

P2860

Human disposition, metabolism and excretion of etamicastat, a reversible, peripherally selective dopamine β-hydroxylase inhibitor.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P932